- Home
- COLL vs CAL Comparison
COLL vs CAL Comparison
Compare COLL & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- CAL
- Stock Information
- Founded
- COLL 2002
- CAL 1878
- Country
- COLL United States
- CAL United States
- Employees
- COLL N/A
- CAL N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- CAL Shoe Manufacturing
- Sector
- COLL Health Care
- CAL Consumer Discretionary
- Exchange
- COLL Nasdaq
- CAL Nasdaq
- Market Cap
- COLL 1.1B
- CAL 1.1B
- IPO Year
- COLL 2015
- CAL N/A
- Fundamental
- Price
- COLL $33.35
- CAL $19.76
- Analyst Decision
- COLL Strong Buy
- CAL Hold
- Analyst Count
- COLL 5
- CAL 2
- Target Price
- COLL $43.80
- CAL $30.00
- AVG Volume (30 Days)
- COLL 486.5K
- CAL 805.5K
- Earning Date
- COLL 02-20-2025
- CAL 12-05-2024
- Dividend Yield
- COLL N/A
- CAL 1.42%
- EPS Growth
- COLL 757.11
- CAL 3.15
- EPS
- COLL 2.16
- CAL 4.49
- Revenue
- COLL $599,245,000.00
- CAL $2,780,579,000.00
- Revenue This Year
- COLL $13.20
- CAL N/A
- Revenue Next Year
- COLL $17.63
- CAL $1.07
- P/E Ratio
- COLL $15.42
- CAL $4.39
- Revenue Growth
- COLL 9.62
- CAL N/A
- 52 Week Low
- COLL $28.39
- CAL $19.75
- 52 Week High
- COLL $42.29
- CAL $44.51
- Technical
- Relative Strength Index (RSI)
- COLL 62.31
- CAL 24.77
- Support Level
- COLL $32.29
- CAL $19.90
- Resistance Level
- COLL $33.99
- CAL $21.25
- Average True Range (ATR)
- COLL 1.29
- CAL 0.83
- MACD
- COLL 0.51
- CAL 0.01
- Stochastic Oscillator
- COLL 87.40
- CAL 0.00
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About CAL Caleres Inc.
Caleres Inc is a footwear retailer in the United States. The Company's business are organized into two reportable segments are famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of famous Footwear retail stores, famousfootwear.com and famousfootwear.ca. The Brand Portfolio segment offers retailers and consumers a carefully cultivated portfolio of top brands. This segment is comprised of wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear to online retailers, national chains, department stores, mass merchandisers and independent retailers, as well as Company owned famous Footwear, Sam Edelman, Naturalizer and Allen Edmonds stores and e-commerce businesses.